FBRX

Forte Biosciences Inc.

FBRX·34962G208·US·Common Stock·Healthcare - Biotechnology-13D/G

FBRX (Forte Biosciences Inc.) is held by 57 institutional investors as of Q2 2026. Largest holders: FEDERATED HERMES, INC. ($44.8M), FRED ALGER MANAGEMENT, LLC ($30.6M), BlackRock, Inc. ($26M). Net institutional sentiment: Mixed.

57
Holders
(3 Elite)
$247.7M
Total Value
62% (66)
Consensus
41 buying - 25 selling
13F: Insider & Congress: Updated regularly
FBRX

Smart Money Verdict

View all
Loading verdict
Held by 57 funds
3 elite

Who's Trading

Source dates: Price Aug 26, 2026 · Insiders Aug 27, 2026 · Activists Aug 14, 2026 · Congress none

InsiderKSKornfeld StevenU 4K shAug 27, 2026
InsiderGWGRYSKA DAVID WU 6K shAug 27, 2026
InsiderRARiley Antony AU 43K shAug 27, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.1M(+19.5%)$44.8M0.1%+389.55%
35
Increased
1.4M(+13.0%)$30.6M0.1%+325.14%
39
Increased
1.2M(+1755.0%)$26M0.0%+265.54%
46
Increased
861,737(+62.1%)$18.3M0.0%+219.21%
41
Increased
712,753(+114.7%)$15.1M0.0%+281.64%
45
Decreased
700,000(-26.3%)$14.9M0.0%+260.62%
0
Increased
655,199(+93.9%)$13.9M0.0%+256.80%
45
Increased
547,415(+134.6%)$11.6M0.0%+231.39%
45
Increased
502,826(+47.6%)$10.7M0.0%+299.24%
38
Increased
473,280(+277.3%)$10.1M0.0%+302.77%
45
Increased
418,891(+274.7%)$8.9M0.0%+260.42%
44
Increased
328,522(+499.3%)$7M0.0%+269.88%
44
Increased
303,100(+257.4%)$6.4M0.0%+241.40%
44
Increased
164,557(+704.7%)$3.5M0.0%+251.52%
43
Increased
150,887(+536.3%)$3.2M0.0%+276.83%
43
Increased
136,174(+88.9%)$2.9M0.0%+224.69%
41
New
133,771$2.8M0.0%+262.31%
36
New
108,347$2.3M0.0%+262.31%
36
Decreased
70,409(-23.3%)$1.5M0.0%+197.26%
0
New
47,043$999,6640.0%+262.31%
35

Showing 1-20 of 67

1 / 4
FBRXFBRXForte Biosciences Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used